VitalHub Update - Company Adds Over $1,000,000 in Q4 2020 Organic Growth to Annualized Contract Value
January 19 2021 - 6:30AM
VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased
to report that the Company had organic growth in excess of
$1,000,000 in new Annualized Contract Value Revenue during Q4/2020.
The Company defines Annualized Contract Value
(ACV) as the contracted annual recurring revenue relating to
renewable software license fees and maintenance services. ACV
revenue typically has gross margin above 85%. As a result of the
organic growth in Q4/2020, VitalHub’s ACV is now in excess of $14.5
million on a Company-wide basis, an increase of 7.4% from the end
of Q3/2020. 75% of this revenue was generated from the UK
marketplace, and the remainder from the rest of the world.
The Company is rapidly expanding, as evidenced
by the recently announced procurement of 8 new contracts that have
contributed to the growth in ACV. In addition, VitalHub has
completed various transactions in the community, mental health,
long-term care sectors, and through the MCAP and Oculys business
units. The Company completed the following previously announced
material transactions in Q4/2020:
- Licensing of Synopsis iQ to
Worcestershire Acute Hospitals NHS Trust
- Large-scale expansion of the
licensing contract with King’s College Hospital NHS Foundation
Trust
- Licensing of digital outpatient
management solutions to the Royal Victorian Eye and Ear Hospital in
partnership with Australia’s Device Technologies
- Licensing of Synopsis iQ to the
Northumbria Healthcare NHS Foundation Trust
- Expansion of the licensing contract
with East Suffolk and North Essex NHS Foundation Trust
- Deployment of a contract for
Transforming Systems’ SHREWD products with Bedfordshire, Luton and
Milton Keynes Integrated Care System
- Multi-year deployment of a contract
for Transforming Systems’ SHREWD products with NHS Herefordshire
and Worcestershire CCG
- Expansion of the licensing contract
for Synopsis iQ with King’s College Hospital NHS Foundation
Trust
Much of VitalHub’s organic growth in ACV has
been generated through the adoption and sale of the Company’s
proprietary Synopsis and SHREWD product sets.
SHREWD is a product portfolio of real-time
operational management tools, designed for all tiers of complexity
that can span across health systems. The cloud-based SHREWD
platform and portfolio of modules has the ability to take complex
data from all system providers across health and social care,
creating clear visibility of pressure points and potential impact
on demand and capacity.
The Synopsis products allows hospitals to manage
the entire assessment process – from initial questionnaire through
to post-operative outcomes – digitally, removing the paper trail,
reducing triage times, and cutting cancellation rates. Synopsis is
a vital tool for health systems, providing clarity, efficiency, and
value; having the proven ability to reduce cancellation rates and
risk, increasing patient throughput and theatre utilization.
“Our recent acquisitions in 2020 have added to
our strong set of product offerings, giving VitalHub a robust suite
of solutions that are currently providing a high degree of value to
healthcare organizations around the world. Due in part to our great
customer reference base, and also to the strong team of industry
experts deploying our offerings, other healthcare organizations are
purchasing our digitally-enabled solutions to become more
streamlined and efficient,” said Dan Matlow, CEO of VitalHub.
“VitalHub has achieved its strong revenue growth not only through
acquisitions. As our organic growth has been demonstrating, our
solutions are each industry leaders in their respective markets. We
are excited about the future of these products and are confident in
their ability to meet the demands of health systems
internationally. This organic growth is further proof that we are
able to grow both organically and through M&A via our
two-pronged growth strategy.”
ABOUT VITALHUB
Software for Health and Human Services providers
designed to simplify the user experience & optimize
outcomes.
VitalHub provides technology to Health and Human
Services providers including; Hospitals, Regional Health
Authorities, Mental Health, Long Term Care, Home Health, Community
and Social Services. VitalHub solutions span the categories of
Electronic Health Record (EHR), Case Management, Care Coordination,
Patient Flow & Operational Visibility, and DOCit Mobile
Apps.
The Company has a robust two-pronged growth
strategy, targeting organic growth opportunities within its product
suite, and pursuing an aggressive M&A plan. Currently,
VitalHub serves 275+ clients across Canada, USA, UK,
Australia, Qatar, and Latvia. VitalHub is based in Toronto, Canada,
with an offshore development hub in Sri Lanka. The Company is
publicly traded on the TSX Venture Exchange under the symbol
“VHI”.
CAUTIONARY STATEMENT
This press release includes forward-looking
statements regarding the Corporation and its business, which may
include, but is not limited to, statements with respect to the
appointment of a new directors. Often, but not always,
forward-looking statements can be identified by the use of words
such as "plans", "is expected", "expects", "scheduled", "intends",
"contemplates", "anticipates", "believes", "proposes" or variations
(including negative variations) of such words and phrases, or state
that certain actions, events or results "may", "could", "would",
"might" or "will" be taken, occur or be achieved. Such statements
are based on the current expectations of the management of each
entity and are based on assumptions and subject to risks and
uncertainties. Although the management of each entity believes that
the assumptions underlying these statements are reasonable, they
may prove to be incorrect. The forward-looking events and
circumstances discussed in this release, may not occur by certain
specified dates or at all and could differ materially as a result
of known and unknown risk factors and uncertainties affecting the
companies, including risks regarding the technology industry,
failure to obtain regulatory or shareholder approvals, market
conditions, economic factors, the equity markets generally and
risks associated with growth and competition. Although the
Corporation has attempted to identify important factors that could
cause actual actions, events or results to differ materially from
those described in forward-looking statements, there may be other
factors that cause actions, events or results to differ from those
anticipated, estimated or intended. No forward-looking statement
can be guaranteed. Except as required by applicable securities
laws, forward-looking statements speak only as of the date on which
they are made and the Corporation undertakes no obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future events, or otherwise.
CONTACT INFORMATION
Dan MatlowChief Executive Officer, Director(416)
727-9061dan.matlow@vitalhub.com
Vitalhub (TSXV:VHI)
Historical Stock Chart
From Dec 2024 to Jan 2025
Vitalhub (TSXV:VHI)
Historical Stock Chart
From Jan 2024 to Jan 2025